Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

2.2K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.2K
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

900
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
900
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

545
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
545
Second Order systems II01:18

Second Order systems II

414
In an underdamped second-order system, where the damping ratio ζ is between 0 and 1, a unit-step input results in a transfer function that, when transformed using the inverse Laplace method, reveals the output response. The output exhibits a damped sinusoidal oscillation, and the difference between the input and output is termed the error signal. This error signal also demonstrates damped oscillatory behavior. Eventually, as the system reaches a steady state, the error diminishes to zero.
414
First Order Systems01:21

First Order Systems

438
First-order systems, such as RC circuits, are foundational in understanding dynamic systems due to their straightforward input-output relationship. Analyzing their responses to different input functions under zero initial conditions reveals significant insights into system behavior.
When a first-order system is subjected to a unit-step input, its response is characterized by its transfer function. By applying the Laplace transform of the unit-step input to the transfer function, expanding the...
438
Second Order systems I01:20

Second Order systems I

620
A servo system exemplifies a second-order system, featuring a proportional controller and load elements that ensure the output position aligns with the input position. The relationship between these components is described by a second-order differential equation. Applying the Laplace transform under zero initial conditions yields the transfer function, showing how inputs are converted to outputs in the system.
By reinterpreting the system, one can derive the closed-loop transfer function, which...
620

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Scleroderma Clinical Trials Consortium (SCTC) outcome instruments for evaluation of systemic sclerosis.

Journal of scleroderma and related disorders·2026
Same author

Discordance Between Patient and Physician Global Assessments in Early Systemic Sclerosis.

Arthritis care & research·2026
Same author

Artificial Intelligence-Aided Lung Ultrasound Detection of Interstitial Lung Disease in Systemic Sclerosis and Inflammatory Myopathy.

Arthritis care & research·2026
Same author

A Phase 3 Trial of Brepocitinib in Dermatomyositis.

The New England journal of medicine·2026
Same author

Autoantibodies as biomarkers of cancer risk in dermatomyositis.

JID innovations : skin science from molecules to population health·2026
Same author

RNA origin of sex-biased immunity.

Molecular therapy. Nucleic acids·2026

Related Experiment Video

Updated: Feb 15, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.9K

Digital ulcers in patients with systemic sclerosis.

Lorinda Chung1, David Fiorentino

  • 1Stanford University School of Medicine, Department of Immunology and Rheumatology, 1000 Welch Road, Suite #203, Stanford, CA 94305, USA. shauwei@stanford.edu

Autoimmunity Reviews
|January 25, 2006
PubMed
Summary

Digital ulcers (DU) in systemic sclerosis (SSc) are painful necrotic lesions. This review covers current and investigational therapies for DU treatment and prevention in SSc patients.

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.1K
Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis
07:00

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis

Published on: October 13, 2016

8.7K

Related Experiment Videos

Last Updated: Feb 15, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.9K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.1K
Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis
07:00

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis

Published on: October 13, 2016

8.7K

Area of Science:

  • Rheumatology
  • Dermatology
  • Vascular Medicine

Background:

  • Digital ulcers (DU) affect up to 50% of systemic sclerosis (SSc) patients, causing significant pain and disability.
  • DU pathogenesis varies by location: distal digit DU involve ischemia (vasospasm, thrombosis), while bony prominence DU result from microtrauma and poor healing in avascular tissue.
  • Raynaud's phenomenon is a key factor in digital ischemia contributing to DU development.

Purpose of the Study:

  • To review current and investigational therapies for the management of digital ulcers (DU) in patients with systemic sclerosis (SSc).
  • To provide a comprehensive overview of treatment and prevention strategies for DU in SSc.

Main Methods:

  • Literature review of available and investigational therapies for DU in SSc.
  • Synthesis of information on pathogenesis and management approaches.

Main Results:

  • DU management involves non-pharmacologic and pharmacologic modalities.
  • Therapeutic strategies address both ischemic and microtrauma-related DU.
  • Investigational therapies aim to improve healing and prevent recurrence.

Conclusions:

  • Effective management of DU in SSc requires addressing underlying pathogenetic mechanisms.
  • A combination of existing and novel therapies is crucial for improving patient outcomes.
  • Further research into investigational treatments holds promise for reducing DU burden in SSc.